Stan Musial is an accomplished executive with 30 years of leadership experience in the life sciences sector, serving as EVP and CFO for both private and public companies, including Promontory Therapeutics, Aruvant Sciences, Xenikos B.V., EryDel SpA and Egalet Corporation. He has raised nearly $1 billion in capital, guided companies through private raises and public offerings on NASDAQ. Mr. Musial has played a key role in operational strategy, organizational growth, product expansion, and M&A, and now serves as a fractional Chief Financial Officer to Persevere Therapeutics.